Finance

Lists
Why is 605033 down 2,41%?
Dive Deeper
605033:SHA
Shaanxi Meibang Pharmaceuticl Grp Co Ltd
CNÂ¥18,66
-2,41%
(-0,46) 1D
15 Okt., 15:00:02 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 605033...
Open
CNÂ¥18,97
High
CNÂ¥19,00
Low
CNÂ¥18,51
Mkt. cap
2,69 mjd
Avg. vol.
3,46 m
Volume
1,88 m
Dividend
0,80%
Quarterly dividend
CNÂ¥0,04
Ex-dividend date
17 Jun. 2026
P/E ratio
39,67
52-wk high
CNÂ¥34,69
52-wk low
CNÂ¥15,81
EPS
CNÂ¥0,47
No. of employees
1 k
Open
CNÂ¥18,97
High
CNÂ¥19,00
Low
CNÂ¥18,51
Mkt. cap
2,69 mjd
Avg. vol.
3,46 m
Volume
1,88 m
Dividend
0,80%
Quarterly dividend
CNÂ¥0,04
Ex-dividend date
17 Jun. 2026
P/E ratio
39,67
52-wk high
CNÂ¥34,69
52-wk low
CNÂ¥15,81
EPS
CNÂ¥0,47
No. of employees
1 k
News stories
From web sources and news partners
About Shaanxi Meibang Pharmaceuticl Grp Co Ltd
CEO-
Employees1,12 k
Founded05 Aug. 1998
Headquarters-
Sector-
Websitemeibang.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
123,56 m
303,07 m
336,34 m
218,60 m
Cost of goods sold
79,06 m
213,68 m
212,57 m
141,96 m
Cost of revenue
79,06 m
213,68 m
212,57 m
141,96 m
Research and development expenses
20,44 m
22,88 m
20,37 m
22,55 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
31,99 m
55,73 m
49,16 m
40,40 m
Operating expense
44,93 m
77,94 m
78,96 m
63,87 m
Total operating expenses
123,98 m
291,63 m
291,53 m
205,84 m
Operating income
-426,70 k
11,44 m
44,81 m
12,77 m
Other non operating income
1,27 m
-1,41 m
248,76 k
-134,83 k
EBT including unusual items
-786,23 k
16,07 m
44,95 m
15,90 m
EBT excluding unusual items
2,49 m
12,36 m
46,26 m
13,90 m
Income tax expense
-845,03 k
3,60 m
9,33 m
453,66 k
Effective tax rate
107,48%
22,42%
20,75%
2,85%
Other operating expenses
-164,41 k
2,54 m
1,12 m
-2,49 m
Net income
58,80 k
12,47 m
35,62 m
15,45 m
Net profit margin
0,05%
4,11%
10,59%
7,07%
Earnings per share
-
-
-
-
Interest and investment income
1,69 m
2,69 m
1,45 m
1,36 m
Interest expense
-28,67 k
-367,68 k
-247,12 k
-77,30 k
Net interest expenses
1,66 m
2,32 m
1,20 m
1,28 m
Depreciation and amortization charges
-
-
-
-
EBITDA
4,68 m
19,24 m
52,61 m
24,48 m
Gain or loss from assets sale
-42,87 k
-187,58 k
-
26,40 k
AI content may include mistakes. Learn more
Google-programme